Janssen hands back rights to Hanmi’s diabetes/obesity drug
The drug “fell short” of Janssen’s expectations on blood glucose control in obese patients
Read More
Tag: Hanmi
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
